It is a pharma private limited company based in New Delhi, Delhi, India, established in 2014.
2014 | New Delhi, Delhi, India | Struck OffMadoc Pharmaceuticals Private Limited, a struck off private limited company, was established on 07 August 2014 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51100DL2014PTC270055. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.48 Cr.
Formerly known as Meryl Pharmaceuticals Private Limited. Its leadership includes Tarun Garg (Director), Archna Chaturvedi (Director), Naveen Kalra (Director). Past directors included Archna Chaturvedi, Naveen Kalra, Meera Mallick. Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at H.No.A-18, Iii Floor, Gulab Bagh, Kh No- 909, A-Block, Post Office Uttam N, Agar, New Delhi, Delhi, 110059.
U51100DL2014PTC270055
270055
07 August 2014
₹2.50 Cr
₹2.48 Cr
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Madoc Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Tarun Garg | Director | 07 Aug 2014 | Current |
| Archna Chaturvedi | Director | 08 Oct 2014 | Current |
| Naveen Kalra | Director | 08 Oct 2014 | Current |
| Raj Kumar Mallick | Director | 07 Aug 2014 | Current |
| Tanuj Garg | Director | 08 Oct 2014 | Current |
| Madhukar Chaturvedi | Director | 08 Oct 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Oct 2016 | Past |
| Pramod Abcsdd | Additional Director | 21 Sep 2015 | Past |
| Pramod Abcsdd | Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 21 Sep 2015 | Past |
| Pramod Abcsdd | Director | 03 Oct 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Madoc Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 43.92% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
In 2018, Madoc Pharmaceuticals had a promoter holding of 4.24% and a public holding of 95.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Madoc Pharmaceuticals has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Madoc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madoc Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Madoc Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was documented.
Progress on Madoc Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Delhi. was documented.
Archna Chaturvedi was appointed as a Director was appointed as a Director on 08 Oct 2014 & has been associated with this company since 11 years 3 months . was recorded as a recent event.
Progress on Naveen Kalra was appointed as a Director was appointed as a Director on 08 Oct 2014 & has been associated with this company since 11 years 3 months . was documented.
The activity Tanuj Garg was appointed as a Director was appointed as a Director on 08 Oct 2014 & has been associated with this company since 11 years 3 months . was completed.
Progress on Madhukar Chaturvedi was appointed as a Director was appointed as a Director on 08 Oct 2014 & has been associated with this company since 11 years 3 months . was documented.
The CIN of Madoc Pharmaceuticals Private Limited is U51100DL2014PTC270055.
Madoc Pharmaceuticals Private Limited is headquartered at H.No.A-18, Iii Floor, Gulab Bagh, Kh No- 909, A-Block, Post Office Uttam N, Agar, New Delhi, Delhi, 110059.
Madoc Pharmaceuticals Private Limited was incorporated on 07 August 2014.
The current directors of Madoc Pharmaceuticals Private Limited are
The primary industry of Madoc Pharmaceuticals Private Limited is Pharma.
Madoc Pharmaceuticals Private Limited is unlisted.
The authorized capital of Madoc Pharmaceuticals Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.48 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX